摘要
Hemodialysis,the most common modality of renal replacement therapy,is critically required to remove uremic toxins from the blood of patients with end-stage kidney disease.However,the chronic inflammation,oxidative stress as well as throm-bosis induced by the long-term contact of hemoincompatible hollow-fiber membranes(HFMs)contribute to the increase in cardiovascular diseases and mortality in this patient population.This review first retrospectively analyzes the current clini-cal and laboratory research progress in improving the hemocompatibility of HFMs.Details on different HFMs currently in clinical use and their design are described.Subsequently,we elaborate on the adverse interactions between blood and HFMs,involving protein adsorption,platelet adhesion and activation,and the activation of immune and coagulation systems,and the focus is on how to improve the hemocompatibility of HFMs in these aspects.Finally,challenges and future perspectives for improving the hemocompatibility of HFMs are also discussed to promote the development and clinical application of new hemocompatible HFMs.
基金
National Natural Science Foundation of China(No.51773127,51873115 and 52073190)。
